Surge in Aurobindo Pharma Call Options: 10,901 Contracts at Rs 1300 Strike Price
Aurobindo Pharma Ltd. has become a focal point in the pharmaceuticals sector, with significant trading in call options and a notable increase in stock price. The company demonstrated strong trading activity, with a substantial turnover and open interest, while maintaining favorable liquidity and performance relative to its recent averages.
Aurobindo Pharma Ltd. has emerged as one of the most active stocks in the pharmaceuticals and drugs sector today, with significant trading activity in its call options. The stock, trading under the ticker AUROPHARMA, saw 10,901 contracts traded for call options set to expire on April 24, 2025, at a strike price of Rs 1300. This activity generated a turnover of approximately Rs 1156.05 lakhs, while the open interest stood at 1,842 contracts, indicating a robust interest in this option.In terms of price performance, Aurobindo Pharma opened with a notable gain of 6.15% and reached an intraday high of Rs 1267.3, reflecting a 9.45% increase. Despite this positive movement, the stock underperformed its sector by 0.25%, although it has shown a consecutive gain over the past two days, accumulating a total return of 3.87%. The stock's weighted average price suggests that more volume was traded closer to its low price, and it remains above its 5-day, 20-day, and 50-day moving averages, yet below the 100-day and 200-day averages.
Overall, Aurobindo Pharma's trading activity today highlights its position within the pharmaceuticals sector, which has gained 2.04%. The stock's liquidity remains favorable, with a delivery volume of 6.05 lakhs, reflecting a 33.68% increase against the 5-day average.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
